2. Forward Looking Statements, Reconciliation and Use
of Non-GAAP Measures to U.S. GAAP
Forward-Looking Statements
This presentation may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When
used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and
variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based
upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or
that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the
forward-looking statements contained in this presentation. Numerous factors, many of which are beyond the company’s control, could cause
actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s
filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the
company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made
or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP
This presentation reflects three performance measures, operating EBITDA, adjusted earnings per share, and net debt as non-U.S. GAAP
measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for
operating EBITDA is operating profit; for adjusted earnings per share is earnings per common share-diluted; and for net debt is total debt.
Use of Non-U.S. GAAP Financial Information
§ Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing
operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other
charges and adjustments. Our management believes operating EBITDA is useful to investors because it is one of the primary measures
our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating
EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of
operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical
calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies.
Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not
consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the
amount used in our debt covenants.
§ Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to
common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic
common shares, diluted preferred shares, and options valued using the treasury method. We provide guidance on an adjusted earnings
per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure because a forecast of
Other Items is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to
management and investors regarding various financial and business trends relating to our financial condition and results of
operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided
with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be
considered in isolation or as a substitute for U.S. GAAP financial information.
§ Net debt is defined as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure
provides useful information to management and investors regarding changes to the company’s capital structure. Our management and
credit analysts use net debt to evaluate the company's capital structure and assess credit quality. This non-U.S. GAAP information is
not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
2
3. An Attractive Hybrid Business Model
2006 1H2007
Revenue1 (in $ millions) $6,656 $3,111
Operating EBITDA1 (in $ millions) $1,244 $674
Adjusted EPS $3.00 $1.75
Celanese
Commodity Intermediate Specialty Consumer
Oil & Gas
Chemicals Products Products Products
• Dow*
• Exxon • Dow* • Rohm & Haas* • Motorola
• Eastman*
• BP • Lyondell • ICI* • Toyota
• PPG*
• Shell • Methanex • Sherwin-Williams
• FMC* • Siemens
Balance of intermediate & specialty products
* Celanese internal peer group
3 Includes Other Operating Segment, with Revenue of $257 and $117 and Operating EBITDA of ($111) and ($29), respectively
1
4. Balanced Global and End Market Positions
Paints &
Coatings
Food and Beverage Textiles
14%
5% 6%
Automotive
Consumer
9%
and Industrial
40% 35% 25%
Adhesives
4%
Consumer /
Medical
Construction Applications
8% 11%
Chemical Additives
Performance Industrial
6% Applications
3%
Filter Media
Paper &
Packaging 14% Other
9% 11%
Notes:
Includes oxo alcohol and polyol derivative divestiture and APL acquisition
End use breakdown based on 2006 est. external sales revenue
4
5. Execution…Growth…Value
► Phase I : Execution – 2000 to 2006
Execute transformation strategy
► Phase II: Growth – 2007 to 2010
Celanese earnings growth strategy
► Ongoing: Value – Deliver solid financial results and shareholder
value
Continue to create value in excess of the peer group
5
6. Focus and strengthen portfolio…
2000 to 2006
Portfolio Strategy
► Invest in specialty businesses
► Build strength in differentiated intermediates
► Extend the acetyl chain globally
► Reduce exposure to non-differentiated, more commodity businesses
► Divest non-core business lines
Acquisitions Divestitures
Air Products PVOH Oxo alcohols Vectran
Clariant Emulsions Polyol derivatives Emulsion Powders
Vinamul Trespaphan DH Actives
Acetex Nylon Estech JV
APL Acrylates Emulsions Greece
PBI COC
Fuel Cells
Total Revenue Impact1 $1.8 B ($1.8 B)
1
6 Data from the year in which the transaction occurred
7. Enhanced market position; reduced commodity
exposure
% Revenue from Products % Revenue from Specialty
Holding #1 or #2 Position Businesses
2000 20061,2 2000 20061
~95%
Nutrinova Total Revenue
$6.2 B
~70% Acetate 5%3
Total Revenue
$4.9 B
Ticona
Nutrinova 40%
33%
Acetate
Ticona
31%
55%
Chemical Chemical
Products Products 36%
Specialty Products
Differentiated Intermediates
Non-differentiated Intermediates
1IExcludes results from Oxo alcohol business; includes results from APL acquisition
2~95% #1 or #2 with the planned 2007 closure of all Celanese methanol production
7 3Primarily methanol and formaldehyde revenue
8. Significantly improved earnings profile since 2000
Operating EBITDA Growth1
2000 – 2006 ($MM)
~1,180
40-45
130-135
80-85
90-95
290-300
528
Cost
Increase in Portfolio 2006 Proforma
Baseline 2000 Volume Margin
Reduction net
Earnings from Optimization
of Inflation
Affiliates
1Includesestimates for oxo alcohol and polyol derivative divestiture and APL acquisition – Actual 2006 results were $1,244 million
All numbers are based on CE estimates
8
9. Execution…Growth…Value
► Phase I : Execution – 2000 to 2006
Execute transformation strategy
► Phase II: Growth – 2007 to 2010
Celanese earnings growth strategy
► Ongoing: Value – Deliver solid financial results and shareholder
value
Continue to create value in excess of the peer group
9
10. Realigning the businesses to accelerate growth
Building Block Differentiated Intermediates Specialty Products
Advanced
Engineered Engineered
Engineered
Formaldehyde
Plastics
Materials –
AEM
Raw
Raw (Ticona)
Materials
Materials Acetate
Acetate
Anhydride and
esters
Nutrinova
Nutrinova
Acetic Acid
Emulsions/
Emulsions
VAM
PVOH
Consumer and
Acetyl
Industrial
Intermediates
Specialties - CIS
10
11. 2007 – 2010: Celanese Earnings Growth Strategy
Celanese 2010 Objective:
$300-$350 million
EBITDA Growth
Business Specific Operational Balance
Asia
Excellence Sheet
►Nanjing ►Productivity ►Recapitalized
Revitalization Innovation Organic
Complex improvements balance sheet
more than offset (April 2007)
►Affiliates
inflation ►Continue to
and Ticona – new –
►Consumer ► ►Acetyls evaluate capital
►SG&A
Industrial products and continued improvements structure
Specialties applications greater than opportunities
market growth in
Acetic Acid and
VAM
$300 - $350 million improvement in EBITDA profile
11
12. Asia: Enhancing Celanese’s geographic lead
2010E Regional Split
2006 Regional Split
Europe
Europe
Revenue
Revenue Asia
Asia
30-35%
25%
Americas
Americas
Europe Europe
Earnings
Earnings Asia
Asia
45-55%
~30%
Americas
Americas
Approximately 50% of earnings from the fastest growing region
Note: Revenue breakdown based on Celanese 2006 consolidated net sales (does not include sales from equity and cost investments).
12
13. Consumer Specialties (CS): Acetate drives
earnings growth
Acetate Operating EBITDA Impact
2004 – 2008E
$250
h
wt
ro
sG Acetate Revitalization
ing
$200
rn
Ea Revitalization of North
►
0%
0
>1 American and
$ MM
$220 -
$150
European Businesses
230MM
Expansion of China
►
Joint Ventures
$100
Integration of Acetate
►
Products Limited (APL)
$50
2004 2005 2006 2007E 2008E
1 2
Acetate Seg. EBITDA JV Dividends APL
Acetate Revitalization will continue to add incremental EBITDA
EBITDA as reported excluding special charges, Restructuring in Operations, Other charges.
1
13 JV dividends from cost investments
2
14. Industrial Specialties (IS): Optimize / revitalize for
growth and productivity
Vertical Integration via Acquisition: Maximize Business Performance
$200 MM to $1,050 MM
2007 2008 2009
#1 Global Vinyl Emulsions Producer
Marketplace Interface
Sales 2006E in MM$
Enhance customer focus
►
1,200
Revitalize innovation
►
Focus on
1,000 Consolidate and streamline R&D
►
Innovation
functions
800 Build on capabilities in NA / Asia
►
$MM
600
Operational Excellence
400
200 Capture productivity gains
►
Consolidate manufacturing footprint (YE2008
►
0
completion) / enhance production capabilities
PVOH Clariant Vinamul Acquired Focus on
Streamline supply chain
►
('99) ('02) ('05) business
Controllables Standardize processes, redesign workflows
►
base
Accelerate Six Sigma
►
> $50MM in incremental EBITDA opportunity by 2010
14
15. AEM: Focus on High Performance
Polymers and Thermoplastics
Global High Performance Polymer and Engineering Thermoplastics
2006E: ~8 MM tons (2006E Growth = 6 %)
€ 100 / kg
€ 10 / kg High Performance Polymers (HPP)
4% Engineering Thermoplastics (ETP)
€ 3 / kg
Performance
others = 3 %
Standard Polymers
96 %
PU = 6 %
PET = 5 %
ABS, SAN, ASA: 4 %
€ 1 / kg
PVC = 17 % PS, EPS = 9 %
PE = 34 % PP = 19 %
Range of Products
Comprising: PA 6 & PA 66, PA 11 and PA 12, PC, POM, PBT, COPE, PET technical, PPE, COC & COP,
UHMW-PE, PPS, LCP, High Performance Nylons, PEEK, PEI, PES & PSU, PTFE & other fluoropolymers
15
16. AEM: Increase penetration in transportation;
volume growth / product translation in non-
transportation
Transportation Non-Transportation
Advanced Engineered Materials AEM Non-Transportation
type of resins Revenue Growth
in lbs per vehicle
600
2001 6
500 : 8%
CAGR
400
Revenue ($MM)
12
2006E
300
18
2010E
200
100
Highest 40
Current
0
2001 2002 2003 2004 2005 2006
% Non-Automotive Revenue
47% 53%
16
17. Acetyl Intermediates: Continue organic growth
in excess of the market
Celanese Acetic Acid and Vinyl Acetate
► Favorable industry dynamics
Normalized Growth1996-2008E
200 through 2009
180
► Historical “market-plus” growth
160
continues
140
► Commercial production from
120
100 Nanjing began in Q2 2007
80 $600 - $700 million increased revenues
60 from the Nanjing complex by 2010
1996 1998 2000 2002 2004 2006 2008E >$500 million from Acetyls
Acetic Acid VAM GDP
► Translate vinyl-based emulsions
Acetic Acid
success to growing Asian market
(6.3%2)
Celanese: 5.1%
Growth CAGR1
Market3: 4.6%
VAM
(5.3%2)
Celanese : 4.4%
Market3: 3.5%
Global GDP4: 3.1%
17 11996 – 2008 annual growth 2Including the Acetex acquisition 3Source: Tecnon 4Source: CMAI
18. Acetyl Intermediates: High utilization rates
expected through 2009; unmatched operating cost
advantage
2009E Acetic Acid Cost Curve
Acetic Acid Supply-Demand Balance based on Effective Capacity (kt)
12,000
High Cost Supply
10,000
Pampa (under
8,000
review)
Celanese
KT
6,000
technology
4,000
Conventional
MeOH /CO
AO Plus™/Leading
2,000
By-
Competition
prod
0
2004 2005 2006E 2007E 2008E 2009E 4,000 6,000 8,000 10,000
0 12,000
2,000
Capacity
Utilization1(Nov, 2006): 91% 93% 92% 91% 91% 92%
High Cost Capacity
Low Cost Capacity
Demand
1Based on effective capacity at 90% of nameplate (Celanese estimate)
Source: Celanese estimates; Available Public Data
18
19. Execution…Growth…Value
► Phase I : Execution – 2000 to 2006
Execute transformation strategy
► Phase II: Growth – 2007 to 2010
Celanese earnings growth strategy
► Ongoing: Value – Deliver solid financial results and shareholder
value
Continue to create value in excess of the peer group
19
20. Celanese Corporation Financial Highlights
Net sales increased 7% from the prior
2nd Qtr 2nd Qtr ►
in millions (except EPS)
year
2007 2006
● Nanjing startup and improved
pricing partially offset reduced
Net Sales $1,556 $1,457
volumes in Chemical Products
related to Clear Lake
Operating Profit $71 $152
● Volume increases in Ticona
GAAP Net Earnings (Loss) ($117) $103 ● Inclusion of APL sales in Acetate
Products
Special Items
Operating profit decreased 53% due
►
to other expenses related to long-
$106 $37
Other Charges/Adjustments
term management compensation and
$265 --
Refinancing and Related Costs restructuring activities
GAAP net earnings decreased to a
►
Adjusted EPS $0.84 $0.71 loss on expenses related to the debt
refinancing
Effective Tax Rate 28% 28%
Adjusted EPS up 18% to $0.84/share
►
Diluted Share Basis 174.6 172.1 Operating EBITDA increased 5% to
►
$326
Operating EBITDA $326 $310
20
21. 2007 Business Outlook
► Clear Lake impact to continue into
third quarter – unit restarted early
Chemical August
Products ► Full production rates at Nanjing acetic
acid facility
2007 Guidance:
► Continue >2x GDP volume growth
across transportation and non- Adjusted EPS
Ticona transportation end-uses
$2.85 to $3.00
► Continuing high raw material costs
Operating EBITDA
► Improved earnings continue from
Acetate $1,180 to $1,220 MM
revitalization efforts
Products Clear Lake Impact
► Integration of APL acquisition
($0.15) to ($0.25)
► Strong business fundamentals
Performance continue
Products ► Continued volume growth in core
business
21
22. Well positioned for continued growth and value
creation
Primary Growth Focus
Balance Operational EBITDA
Group Asia Revitalization Innovation Organic
Sheet Excellence Impact
Consumer and
EPS Operating EBITDA
X X X X
Industrial > $100MM
Specialties
Advanced
X X X X
Engineered > $100MM
Materials
Acetyl
X X X > $100MM
Intermediates
Celanese Incremental
X X EPS
Corporate
$300 – $350 million increased EBITDA profile plus EPS potential by 2010
22
24. Chemical Products
2nd Qtr 2007 2nd Qtr 2006
in millions
Net Sales $1,002 up 3% $977
Operating EBITDA $176 down 15% $207
Second Quarter 2007:
► Reduced volumes due to unplanned outage of Clear Lake acetic
acid unit
► Successful startup of Nanjing acetic acid unit partially offset volume
loss
► Sales increased due to higher pricing, currency and continued
strong demand
► Pricing strength could not offset margin impact of lower volumes
and higher raw material costs
24
25. Ticona Technical Polymers
2nd Qtr 2007 2nd Qtr 2006
in millions
Net Sales $257 up 12% $230
Operating EBITDA $70 up 6% $66
Second Quarter 2007:
► Net sales increase driven by strong volume growth (8%) and
currency effect (4%)
► Strong demand continues for all major products in Europe and Asia
► Moderate growth in North American automotive and housing
applications supported by strong growth in other end markets
► Volume growth partially offset by higher raw material and energy
costs
25
26. Acetate Products
2nd Qtr 2007 2nd Qtr 2006
in millions
Net Sales $235 up 34% $176
Operating EBITDA $80 up 45% $55
Increased revenues attributable to inclusion of APL acquisition in Q2
►
Continued operating margin improvement with revitalization program
►
Higher dividends from China ventures contributed to EBITDA improvement
►
Performance Products
2nd Qtr 2007 2nd Qtr 2006
in millions
Net Sales $47 down 2% $48
Operating EBITDA $21 $21
Continued volume growth in Sunett™ and favorable currency impacts did
►
not fully offset decrease in non-core volumes
Price reductions in line with company expectations
►
26
27. Impact from Recent Strategic Initiatives
2006
Q3 Q4 HY06
Adjusted EPS (As Reported) $0.79 $0.77 $1.56
Portfolio Enhancements:
Oxo Alcohol Divestiture ($0.08) ($0.13) ($0.21)
Edmonton Methanol Shut Down ($0.04) ($0.07) ($0.11)
Balance Sheet Improvements:
Debt Refinancing $0.04 - $0.06 $0.04 - $0.06 $0.08 - $0.12
Adjusted EPS (Comparable Basis) $0.71 - $0.73 $0.61 - $0.63 $1.32 - $1.36
Divest non-core business lines
►
● Closed sale of oxo alcohol business in Q1 2007
● Discontinued methanol production unit in Q2 2007
Capital structure opportunities
►
● Debt refinancing completed in Q2 2007 (reduced debt by ~$113 MM and lowered interest
expense by ~$10-15MM per quarter)
● Share repurchases (retired 2.4 million shares with Dutch auction and 8.5 million shares
with Board authorized plan – impacts not fully realized in EPS for Q2 2007)
27
28. Share Repurchase Program Impacts
Actual Common Shares Outstanding
Q1 Q2
(amounts in millions) 158.7
Outstanding at 12/31/06
Weighted Average Common Shares Outstanding 159.3 156.9 1.3
Stock option exercises
Convertible Preferred Stock 12.0 12.0
(7.3)
Share repurchases through Q2
Stock Option Exercises 3.1 5.2
152.7
Outstanding at 6/30/07
Restricted Stock Units 0.0 0.5
(3.5)
July share repurchases
Weighted Average Diluted Shares Outstanding 174.4 174.6
149.2
Outstanding at 7/23/07
Share repurchase activity
►
● Dutch auction – retired 2.4 million shares for approximately $72 million
● Board authorized plan – retired a total of 8.5 million shares at ~$38.88/share (program
completed as of July 23, 2007)
EPS impacts not fully realized for Q2 2007 based on weighted average calculation
►
28
29. Project delays continue to allow increasing
demand to absorb new supply
CE Investor Day 2005
Company Capacity Original Date CE Investor Day 2006 Updates
Comments
Fanavaran 150KT Start 2005 Rumored to have started Commercial Production in July,
commissioning 2006
Wujing 200KT Start 2005 No sign of construction Construction under way; Pending
Litigation; Startup expected Mid-
2007
SOPO 150KT Start 2005 Completed, explosion 3 Operational in 1Q 2006; expansion
days later in July, 2006
BP/FPC 300KT Early 2005 December 2005 Commercial Production in 2Q 2006
BP/Yaraco 150KT Early 2005 Operational mid-2005 Commercial Production mid-2005
Lunan 200KT June 2005 Now commercializing Commercial Production in 1Q 2006
Daqing 200KT Late 2006 NA Expected Mid- 2007; replaces high
cost capacity
BP/Sinopec 500KT Start 2008 Construction not yet Construction not yet begun;
begun Expected mid-2009
Sipchem 425KT Start 2008 Website states Q3 2008 Pending Litigation; Expected mid-
2009
Hualu Hengsheng 200KT 2009 Expected Late 2009 Expected Late 2009
29
30. Reg G: Reconciliation of Diluted Adjusted EPS
Adjusted Earnings Per Share - Reconciliation of a Non-U.S. GAAP Measure
Three Months Ended Six Months Ended
June 30, June 30,
2007 2006 2007 2006
(in $ millions, except per share data)
Earnings (loss) from continuing operations
before tax and minority interests (168) 3
134 251
Non-GAAP Adjustments:
1
Other charges and other adjustments 115 166
37 61
- -
Refinancing costs 256 254
Adjusted earnings from continuing operations
before tax and minority interests 203 171 423 312
2
Income tax provision on adjusted earnings (57) (118)
(48) (87)
(1)
Minority interests - - (1)
Adjusted earnings from continuing operations 146 122 305 224
Preferred dividends (3) (2) (5) (5)
Adjusted net earnings available to common shareholders 143 120 300 219
Add back: Preferred dividends 3 2 5 5
Adjusted net earnings for adjusted EPS 146 122 305 224
Diluted shares (millions)
Weighted average shares outstanding 156.9 158.6 158.1 158.6
12.0 12.0
12.0
Assumed conversion of Preferred Shares 12.0
-
0.2
Assumed conversion of Restricted Stock 0.5 -
1.5 4.2 1.4
5.2
Assumed conversion of stock options
Total diluted shares 174.6 172.1 174.5 172.0
Adjusted EPS 0.84 0.71 1.75 1.30
1
See Slide 32 for details
2
The adjusted tax rate for the three and six months ended June 30, 2007 is 28% based on the original full year 2007 guidance.
30
31. Reg G: Reconciliation of Net Debt
Net Debt - Reconcilation of a Non-U.S. GAAP Measure
June 30, December 31,
2007 2006
(in $ millions)
Short-term borrowings and current
installments of long-term debt - third party and affiliates 187 309
3,198
Long-term debt 3,189
3,385 3,498
Total debt
Less: Cash and cash equivalents 470 791
Net Debt 2,915 2,707
31
32. Reg G: Reconciliation of Other Charges and
Other Adjustments
Reconciliation of Other Charges and Other Adjustments
Other Charges:
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2007 2006 2007 2006
Employee termination benefits 25 9 25 11
- -
-
Plant/office closures 2
Total restructuring 25 11 25 11
- -
Insurance recoveries associated with plumbing cases (2) (3)
Long-term compensation triggered by Exit Event 74 - 74 -
3 3
Asset impairments - -
Ticona Kelsterbach relocation 3 - 3 -
3
- 1
Other 4
Total 105 12 106 12
Other Adjustments: 1
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2007 2006 2007 2006
Executive severance & other costs related
- 1
to Squeeze-Out 13 23
- 10
Ethylene Pipeline Exit -
3 5
Business Optimization - -
9 9
Foreign exchange loss related to refinancing transaction - -
2
Discontinued Methanol production (2) 12 31 26
- 4
Other - -
10 25 60 49
Total
115 37 166 61
Total other charges and other adjustments
1
These items are included in net earnings but not included in other charges.
2
Adjusted earnings per share included earnings from its discontinued methanol production which was included in the company's 2007 guidance.
32
33. 33
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
a Non-U.S. GAAP Measure.
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2007 2006 2007 2006
Net Sales
1,002 2,004
Chemical Products 977 1,914
257 519
Technical Polymers Ticona 230 461
235 458
Acetate Products 176 343
47 92
Performance Products 48 97
1
Other Activities 58 117
68 129
(43) (79)
Intersegment eliminations (42) (67)
Total 1,556 1,457 3,111 2,877
Operating Profit (Loss)
91 239
Chemical Products 130 251
32 68
Technical Polymers Ticona 38 79
29 58
Acetate Products 29 52
16 32
Performance Products 16 33
1
Other Activities (97) (120)
(61) (107)
Total 71 152 277 308
Equity Earnings and Other Income/(Expense) 2
18 22
Chemical Products 15 23
16 30
Technical Polymers Ticona 14 29
34 34
Acetate Products 21 21
1 1
Performance Products 1 1
1
Other Activities (2) 3
(4) (3)
Total 67 47 90 71
Other Charges and Other Adjustments 3
30 76
Chemical Products 20 33
5 5
Technical Polymers Ticona (2) (4)
8 9
Acetate Products - -
- -
Performance Products - -
1
Other Activities 72 76
19 32
Total 115 37 166 61
Depreciation and Amortization Expense
37 71
Chemical Products 42 75
17 34
Technical Polymers Ticona 16 32
9 16
Acetate Products 5 12
4 8
Performance Products 4 8
1
12
Other Activities 6 7 12
Total 73 74 141 139
Reg G: Reconciliation of Operating EBITDA
Operating EBITDA
176 408
Chemical Products 207 382
70 137
Technical Polymers Ticona 66 136
80 117
Acetate Products 55 85
21 41
Performance Products 21 42
1
Other Activities (21) (29)
(39) (66)
Total 326 310 674 579
1
Other Activities primarily includes corporate selling, general and administrative expenses
and the results from AT Plastics and captive insurance companies.
2
Includes equity earnings from affiliates, dividends from cost investments and other income/(expense)
3
Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations.
